Self Study Treatment of HCV
Sign In or Register to get started
Treatment of HCV
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
Review all Topics
3
Take the Quiz
Score 80% on 5 questions
4
Give Feedback
Complete a survey
5
Print Certificate
Document work
Section Navigation
- Lesson 1 Overview
Simplified HCV Treatment for All HCV Genotypes - Topic 1
IntroductionActivities- Topic 2
Eligibility for Simplified HCV Treatment: Initial AssessmentActivities- Topic 3
Simplified Treatment: Pretreatment Assessment for Patients without CirrhosisActivities- Topic 4
Recommended Simplified Treatment Regimens for Patients without CirrhosisActivities- Topic 5
Monitoring on and after HCV Treatment in Patients without CirrhosisActivities- Topic 6
Simplified Treatment: Pretreatment Assessment for Patients with Compensated CirrhosisActivities- Topic 7
Recommended Simplified Treatment Regimens for Patients with Compensated CirrhosisActivities- Topic 8
Monitoring On and After Treatment for Patients with Compensated CirrhosisActivities- Topic 9
Treatment InterruptionsSimplified HCV Treatment for All HCV Genotypes Overview
About this Lesson
Last Updated: September 28th, 2023CNE/CMEContinuing Education
This lesson qualifies for:- 1.0 CME AMA PRA Category 1 Credit™, or
- 1.0 CNE contact hour and 1.0 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: November 1st, 2023CNE and CME Review: November 1st, 2023CNE and CME Expiration: October 31st, 2026 (4th Edition)
View CE NoticesSteps to acquire a Certificate for this Lesson:
1Study the Material
Review all Topics2Take the Quiz
Score 80%+3Give Feedback
Complete survey4Print Certificate
Document work4th Edition
First appearance. This Lesson did not appear in the previous edition.Learning Objectives
- Summarize the eligibility criteria for the American Association for the Study of Liver Disease/Infectious Diseases Society of America (AASLD/IDSA) simplified HCV treatment algorithm
- Discuss how to assess liver fibrosis, including identifying decompensated cirrhosis
- List the direct-acting antiviral (DAA) treatment regimens recommended as part of the AASLD/IDSA simplified guidance
- Describe on-treatment monitoring for adults during HCV treatment using the simplified AASLD/IDSA guidance
- Describe appropriate post-treatment monitoring for adults after completing HCV treatment
Lesson Contributors
Authors
Reviewers
Lesson Plan
Funded byCenters for Disease Control and Prevention (CDC)
Cooperative Agreement (CDC-RFA-PS21-2105)Created at
Part of
CME provided by
CNE approved by
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-monorepo-6b5d68fb-2025-11-01-000010 - Topic 2